Yingming Li

1.5k total citations
22 papers, 1.2k citations indexed

About

Yingming Li is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Yingming Li has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Yingming Li's work include Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (5 papers) and Cancer Research and Treatments (4 papers). Yingming Li is often cited by papers focused on Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (5 papers) and Cancer Research and Treatments (4 papers). Yingming Li collaborates with scholars based in United States, China and Australia. Yingming Li's co-authors include Jer‐Tsong Hsieh, Jeffrey M. Bergelson, Takatsugu Okegawa, Arthur I. Sagalowsky, Rey-Chen Pong, R C Pong, Zhi Wang, M. Craig Hall, Ching‐Ping Tseng and Jian Zhou and has published in prestigious journals such as Nucleic Acids Research, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Yingming Li

21 papers receiving 1.2k citations

Peers

Yingming Li
Kathrin M. Bernt United States
Mai Johnson United States
Scott Estes United States
Shu Fen Wen United States
Doris A. Phelps United States
Maria C. Speranza United States
Yingming Li
Citations per year, relative to Yingming Li Yingming Li (= 1×) peers Toshihiko Kuroda

Countries citing papers authored by Yingming Li

Since Specialization
Citations

This map shows the geographic impact of Yingming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingming Li more than expected).

Fields of papers citing papers by Yingming Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingming Li. The network helps show where Yingming Li may publish in the future.

Co-authorship network of co-authors of Yingming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yingming Li. A scholar is included among the top collaborators of Yingming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingming Li. Yingming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yingming, et al.. (2025). Genome Analysis of Coxsackievirus A4 Identified from Herpangina Children in Northern China. Current Microbiology. 82(2). 83–83.
2.
Li, Yingming, et al.. (2024). Research on the surface subsidence characteristics and prediction models caused by coal mining under the reverse fault. Scientific Reports. 14(1). 25316–25316. 2 indexed citations
3.
Li, Yingming, et al.. (2021). CircSOS2 promotes cervical squamous cell carcinoma by regulation of proliferation, cell cycle, apoptosis, migration, invasion, and glycolysis by targeting miR-543/FNDC3B axis. Archives of Biochemistry and Biophysics. 708. 108925–108925. 10 indexed citations
4.
Guan, Jibin, Hong Guo, Tang Tang, et al.. (2021). iRGD‐Liposomes Enhance Tumor Delivery and Therapeutic Efficacy of Antisense Oligonucleotide Drugs against Primary Prostate Cancer and Bone Metastasis. Advanced Functional Materials. 31(24). 46 indexed citations
5.
Li, Yingming, Roger G. Shivas, Baoju Li, & Lei Cai. (2019). Diversity of Moesziomyces (Ustilaginales, Ustilaginomycotina) on Echinochloa and Leersia (Poaceae). MycoKeys. 52. 1–16. 6 indexed citations
6.
Trembley, Janeen H., Betsy T. Kren, Md. Joynal Abedin, et al.. (2019). CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression. Pharmaceuticals. 12(2). 89–89. 15 indexed citations
7.
Ahmed, Khalil, Betsy T. Kren, Md. Joynal Abedin, et al.. (2016). CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors. Oncotarget. 7(38). 61789–61805. 15 indexed citations
8.
Landman, Sean R., Tae Hyun Hwang, Kevin A.T. Silverstein, et al.. (2014). SHEAR: sample heterogeneity estimation and assembly by reference. BMC Genomics. 15(1). 84–84. 6 indexed citations
9.
Li, Yingming, Roger G. Shivas, & Lei Cai. (2014). Three new species of Tilletia on Eriachne from north-western Australia. Mycoscience. 55(5). 361–366. 9 indexed citations
10.
Li, Yingming & Kenneth S. Koeneman. (2008). BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Urologic Oncology Seminars and Original Investigations. 27(1). 112–113. 3 indexed citations
11.
Li, Yingming & Kenneth S. Koeneman. (2008). The zinc finger protein Ras-responsive element binding protein-1 is a coregulator of the androgen receptor: Implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Urologic Oncology Seminars and Original Investigations. 26(1). 110–110. 2 indexed citations
12.
Li, Yingming & Kenneth S. Koeneman. (2008). SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Urologic Oncology Seminars and Original Investigations. 26(1). 110–111. 7 indexed citations
13.
Li, Yingming & Kenneth S. Koeneman. (2008). Phosphoinositide 3-kinase-independent nongenomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains. Urologic Oncology Seminars and Original Investigations. 26(1). 107–108. 6 indexed citations
14.
Melquist, Jonathan, Yingming Li, Bahaa S. Malaeb, et al.. (2006). Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: An orthotopic in vivo model. Urologic Oncology Seminars and Original Investigations. 24(4). 362–371. 10 indexed citations
15.
Yu, Jianxin, Zhenyi Ma, Yingming Li, et al.. (2005). Synthesis and Evaluation of a Novel Gene Reporter Molecule: Detection of b-galactosidase Activity Using 19F NMR of a Fluorinated Vitamin B6 Conjugate+. Medicinal Chemistry. 1(3). 255–262. 17 indexed citations
17.
Okegawa, Takatsugu, Yingming Li, Rey-Chen Pong, & Jer‐Tsong Hsieh. (2002). Cell Adhesion Proteins As Tumor Suppressors. The Journal of Urology. 167(4). 1836–1843. 97 indexed citations
18.
Li, Yingming, Dechao Yu, Yu Chen, et al.. (2001). A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.. PubMed. 61(17). 6428–36. 125 indexed citations
19.
Okegawa, Takatsugu, Yingming Li, R C Pong, et al.. (2000). The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy.. PubMed. 60(18). 5031–6. 189 indexed citations
20.
Pong, Rey-Chen, Yingming Li, M. Craig Hall, et al.. (1999). LOSS OF ADENOVIRAL RECEPTOR EXPRESSION IN HUMAN BLADDER CANCER CELLS- A POTENTIAL IMPACT ON THE EFFICACY OF GENE THERAPY. The Journal of Urology. 112–112. 318 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026